Stockreport

Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change [Seeking Alpha]

Abbott Laboratories  (ABT) 
Last abbott laboratories earnings: 4/16 07:30 am Check Earnings Report
US:NYSE Investor Relations: abbott.com/investors.html
PDF Summary Cardiovascular disease is rising, presenting an opportunity for investors; Abbott Laboratories is well-positioned in the CVD treatment space to benefit from t [Read more]